The Dutch Colorectal Cancer Group (DCCG) is a collaboration between medical disciplines that are relevant for the diagnosis and treatment of colorectal cancer (surgical oncology radiotherapy medical oncology pathology radiology gastroenterology).

  • English
  • Dutch
Current path: Home » > Publications

Others

45. Krol M, Koopman M, Uyl-de Groot C, Punt CJA. A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer. Expert Opin Pharmacother 2007;8:1313-28

46. Tol J, Punt CJA. Targeted therapy in colorectal cancer: an update. Targeted Oncol 2007;2:165-72

47. Simkens L, Tol J, Koopman M, Mol L, Antonini N, van Krieken H, Punt C. Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group. Clin Colorectal Cancer 2008;7:105-9.

48. Punt CJA, Mekenkamp JM, Tol J, Koopman M. Treatment in oncology: Current status of the systemic treatment of metastatic colorectal cancer. Eur J Hosp Pharm Practice 2009;15:62-64

49. Tol J, Punt CJA. Monoclonal Antibodies in the Treatment of Metastatic Colorectal Cancer: A Review. Clin Therapeutics 2010;32-437-53

50. Knijn N, Tol J, Punt CJ. Current issues in the targeted therapy of advanced colorectal cancer. Discov Med 2010;9:328-36.

51. Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, Meijer JW, Tebar M, Riemersma S, van Krieken JH, Punt CJ, Nagtegaal ID. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer 2011;104:1020-6

52. Venderbosch S, de Wilt JH, Teerenstra S, Vincent AD, Loosveld OJ, van Bochove A, Sinnige HA, Creemers GJM,  Tesselaar ME, Mol L, Punt CJ, Koopman M. The prognostic value of resection of the primary tumor in patients with synchronous metastatic colorectal cancer, a retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 2011;18:3252-60

53. Punt CJA, Mol L, Koopman M. Bevacizumab and cancer-related mortality. JAMA 2011;305:2292

54. Simkens LH, Koopman M, Mol L, Veldhuis GJ, Ten Bokkel Huinink D, Muller EW, Derleyn VA, Teerenstra S, Punt CJ. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. Eur J Cancer 2011;47:2560-7

55. van Gils CW, Koopman M, Mol L, Redekop WK, Uyl-de Groot CA, Punt CJ. Adjuvant chemotherapy in stage III colon cancer: Guideline implementation, patterns of use and outcomes in daily practice in The Netherlands. Acta Oncol 2012;51:57-64

Back to top


Site navigation

Back to top


The Dutch Colorectal Cancer Group (DCCG) is a collaboration between medical disciplines that are relevant for the diagnosis and treatment of colorectal cancer (surgical oncology radiotherapy medical oncology pathology radiology gastroenterology).